Skip to main content

Closed

IRMD: IRadimed Corporation Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+11.7% / yr

Operating margin31.9%

ROIC20.2%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio9.46×

Valuation

Unrated

P/E ratio50.2×

Dividend yield1.4%

IRadimed Corporation

IRMDNASDAQ Capital Market·USD·Closed

IRadimed Corporation

IRMDNASDAQ·USD·Closed

$90.86

−4.57%

$90.86

−$4.35 (4.57%)

52W Range

65thpctl

Volume

2.22×avg

Mkt Cap

1.16BUSD

P/E

50.2TTM

Div Yield

1.36%ann

52W Range

65thpctl

Volume

2.22×avg

Market Cap

1.16BUSD

P/E Ratio

50.2TTM

Div Yield

1.36%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings